Article Versions Notes

Huang Y, Li C, Li Z, Wang Q, Huang S, Liu Q, Liang Y. Development and Preclinical Evaluation of [⁶⁸Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression. Pharmaceuticals. 2023; 16(10):1487. https://doi.org/10.3390/ph16101487

Huang, Yong, Chengze Li, Zhongjing Li, Qiong Wang, Size Huang, Qi Liu, and Ying Liang. 2023. "Development and Preclinical Evaluation of [⁶⁸Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression" Pharmaceuticals 16, no. 10: 1487. https://doi.org/10.3390/ph16101487

Huang, Y., Li, C., Li, Z., Wang, Q., Huang, S., Liu, Q., & Liang, Y. (2023). Development and Preclinical Evaluation of [⁶⁸Ga]BMSH as a New Potent Positron Emission Tomography Tracer for Imaging Programmed Death-Ligand 1 Expression. Pharmaceuticals, 16(10), 1487. https://doi.org/10.3390/ph16101487